ログイン

ISBB

ISBB
52問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Which of the following methods used for HIV identification is considered a signal amplification technique? A. Branched chain DNA analysis B. DNA PCR C. Reverse transcriptase PCR D. Nucleic acid sequence-based assay (NASBA)

    A. Branched chain DNA analysis

  • 2

    Which of the following fungal organisms is best diagnosed by an ANTIGEN detection test as opposed to an antibody detection assay? A. Histoplasma B. Cryptococcus C. Candida D. Aspergillus

    B. Cryptococcus

  • 3

    Your cytology laboratory refers a Papanicolaou smear specimen to you for an assay designed to detect the presence of a virus associated with cervical cancer. You perform: A. An ELISA assay for anti-HSV-2 antibodies B. A molecular assay for HSV-2 C. An ELISA assay for HPV antibodies D. A molecular assay for HPV

    D. A molecular assay for HPV

  • 4

    An immunosuppressed patient has an unexplained anemia. The physician suspects a parvovirus B19 infection. A parvovirus IgM test is negative. The next course of action is to tell the physician: A. The patient does not have parvovirus B. A convalescent specimen is recommended in 4 weeks to determine if a fourfold rise in titer has occurred C. A parvovirus PCR is recommended D. That a recent transfusion for the patient’s anemia may have resulted in a false-negative assay and the patient should be retested in 4 weeks

    C. A parvovirus PCR is recommended

  • 5

    What is a general definition for autoimmunity? A. Increase of tolerance to self-antigens B. Loss of tolerance to self-antigens C. Increase in clonal deletion of mutant cells D. Manifestation of immunosuppression

    B. Loss of tolerance to self-antigens

  • 6

    An antinuclear antibody test is performed on a specimen from a 55-year-old woman who has unexplained joint pain. The IFA result is a titer of 40 and a homogeneous pattern. The appropriate followup for this patient is: A. Anti-DNA assay B. Extractable nuclear antigen (ENA) testing C. Retest ANA in 3–6 months D. CH50 complement assay

    C. Retest ANA in 3–6 months

  • 7

    Which disease is likely to show a rim (peripheral) pattern in an immunofluorescence (IF) microscopy test for ANA? A. Mixed connective tissue disease (MCTD) B. Rheumatoid arthritis C. Systemic lupus erythematosus D. Scleroderma

    C. Systemic lupus erythematosus

  • 8

    A patient’s specimen is strongly positive in an ANA ELISA. Which of the following would not be an appropriate follow up to this result? A. Immunofluorescence test on HEp-2 cells B. Specific ENA ELISA tests C. Specific anti-DNA ELISA D. Rheumatoid factor assay

    D. Rheumatoid factor assay

  • 9

    What type of antibodies is represented by the solid or homogeneous pattern in the immunofluorescence test for antinuclear antibodies? A. Antihistone antibodies B. Anticentromere antibodies C. Anti-ENA (anti-Sm and anti-RNP) antibodies D. Anti-RNA antibodies

    A. Antihistone antibodies

  • 10

    What disease is indicated by a high titer of antiSm (anti-Smith) antibody? A. Mixed connective tissue disease (MCTD) B. RA C. SLE D. Scleroderma

    C. SLE

  • 11

    Which disease is least likely when a nucleolar pattern occurs in an immunofluorescence test for antinuclear antibodies? A. MCTD B. Sjögren’s syndrome C. SLE D. Scleroderma

    A. MCTD-

  • 12

    What antibodies are represented by the nucleolar pattern in the immunofluorescence test for antinuclear antibodies? A. Antihistone antibodies B. Anti-dsDNA antibodies C. Anti-ENA (anti-Sm and anti-RNP) antibodies D. Anti-RNA antibodies

    D. Anti-RNA antibodies

  • 13

    Which test would best distinguish between SLE and MCTD? A. Multiplex or ELISA test for anti-SM and anti-RNP B. Immunofluorescence testing using Crithidia as substrate C. Slide agglutination testing D. Laboratory tests cannot distinguish between these disorders

    A. Multiplex or ELISA test for anti-SM and anti-RNP

  • 14

    An ANA test on HEp-2 cells shows nucleolar staining in interphase cells and dense chromatin staining in mitotic cells. The most likely cause of this staining pattern is: A. Antifibrillarin antibody B. Antiribosomal p antibody C. A serum with nucleolar and homogeneous patterns D. Technical artifact

    A. Antifibrillarin antibody

  • 15

    Which immunofluorescence pattern indicates the need for ENA testing by Ouchterlony immunodiffusion, Multiplex, or ELISA assays? A. Homogeneous or solid B. Peripheral or rim C. Speckled D. Nucleolar

    C. Speckled

  • 16

    Which of the following is used in rapid slide tests for detection of rheumatoid factors? A. Whole IgM molecules B. Fc portion of the IgG molecule C. Fab portion of the IgG molecule D. Fc portion of the IgM molecule

    B. Fc portion of the IgG molecule

  • 17

    Which of the following methods is least likely to give a definitive result for the diagnosis of RA? A. Nephelometric measurement of anti-IgG B. Agglutination testing for rheumatoid factor C. Anti CCP D. Immunofluorescence testing for antinuclear antibodies

    D. Immunofluorescence testing for antinuclear antibodies

  • 18

    Which disease might be indicated by antibodies to smooth muscle? A. Atrophic gastritis B. Autoimmune hepatitis C. Myasthenia gravis D. Sjögren’s syndrome

    B. Autoimmune hepatitis

  • 19

    Antibodies to thyroid peroxidase can be detected by using agglutination assays. Which of the following diseases may show positive results with this type of assay? A. Graves’ disease and Hashimoto’s thyroiditis B. Myasthenia gravis C. Granulomatous thyroid disease D. Addison’s disease

    A. Graves’ disease and Hashimoto’s thyroiditis

  • 20

    What is the main use of laboratory tests to detect antibodies to islet cells and insulin in cases of insulindependent diabetes mellitus (IDDM)? A. To regulate levels of injected insulin B. To diagnose IDDM C. To rule out the presence of other autoimmune diseases D. To screen susceptible individuals prior to destruction of β cells

    D. To screen susceptible individuals prior to destruction of β cells

  • 21

    A patient presents with clinical symptoms of celiac disease. Tests for anti-tissue transglutaminase and antigliadin antibodies are negative. Which of the following tests should be ordered? A. IgG level B. HLA DQ typing C. HLA DR typing D. IgM level

    B. HLA DQ typing

  • 22

    A specimen appears to have a perinuclear staining pattern in an antineutrophil cytoplasmic antibody (ANCA) immunofluorescent assay using ethanol fixed neutrophils, suggesting the possibility of a pANCA. On which of the following substrates would this specimen display cytoplasmic speckling? A. Formalin-fixed neutrophils B. Unfixed neutrophils C. HEp-2 cells D. Rabbit kidney tissue

    A. Formalin-fixed neutrophils

  • 23

    Which of the following is a description of a type I hypersensitivity reaction? A. Ragweed antigen cross links with IgE on the surface of mast cells, causing release of preformed mediators and resulting in symptoms of an allergic reaction B. Anti-Fya from a pregnant woman crosses the placenta and attaches to the Fya antigen-positive red cells of the fetus, destroying the red cells C. Immune complex deposition occurs on the glomerular basement membrane of the kidney, leading to renal failure D. Exposure to poison ivy causes sensitized T cells to release lymphokines that cause a localized inflammatory reaction

    A. Ragweed antigen cross links with IgE on the surface of mast cells, causing release of preformed mediators and resulting in symptoms of an allergic reaction

  • 24

    Which in vitro test measures IgE levels against a specific allergen? A. Histamine release assay B. Radioimmunosorbent test (RIST) C. Fluorescent allergosorbent test (FAST) D. Precipitin radioimmunosorbent test (PRIST)

    C. Fluorescent allergosorbent test (FAST)

  • 25

    A patient who is blood group O is accidentally transfused with group A blood and develops a reaction during the transfusion. What antibody is involved in this type II reaction? A. IgM B. IgE C. IgG and IgE D. IgG

    A. IgM

  • 26

    Why is skin testing the most widely used method to test for a type I hypersensitivity reaction? A. It causes less trauma and is more cost effective than other methods B. It has greater sensitivity than in vitro measurements

    B. It has greater sensitivity than in vitro measurements

  • 27

    Which test would measure the coating of red cells by antibody as occurs in hemolytic transfusion reactions? A. Indirect antiglobulin test (IAT) B. Direct antiglobulin test (DAT) C. ELISA D. Hemagglutination

    B. Direct antiglobulin test (DAT)

  • 28

    Which test detects antibodies that have attached to tissues, resulting in a type-II cytotoxic reaction? A. Migration inhibition factor assay (MIF) B. Direct immunofluorescence (IF) C. Immunofixation electrophoresis (IFE) D. Hemagglutination

    B. Direct immunofluorescence (IF)

  • 29

    Which of the following conditions will most likely result in a false-negative DAT test? A. Insufficient washing of RBCs B. Use of heavy chain–specific polyclonal anti-human Ig C. Use of excessive centrifugal force D. Use of a sample obtained by finger puncture

    A. Insufficient washing of RBCs

  • 30

    Which of the following tests is used to detect circulating immune complexes in the serum of some patients with systemic autoimmune diseases such as rheumatoid arthritis? A. Direct immunofluorescence B. Enzyme immunoassay C. Assay of cryoglobulins D. Indirect antiglobulin test

    C. Assay of cryoglobulins

  • 31

    All of the following tests may be abnormal in a type III immune complex reaction except: A. C1q-binding assay by ELISA B. Raji cell assay C. CH50 level D. Mitogen response

    D. Mitogen response

  • 32

    What immune elements are involved in a positive skin test for tuberculosis? A. IgE antibodies B. T cells and macrophages C. NK cells and IgG antibody D. B cells and IgM antibody

    B. T cells and macrophages

  • 33

    A patient receives a transfusion of packed red cells and fresh frozen plasma and develops an anaphylactic, nonhemolytic reaction. She reports receiving a transfusion 20 years earlier. She had no reaction to the previous transfusion, but she did feel “poorly” a few weeks later. Which of the following transfused substances most likely elicited the reaction? A. IgA B. Group A antigen C. Rho (D) antigen D. An antigen belonging to the Duffy system

    A. IgA

  • 34

    A patient deficient in the C3 complement component would be expected to mount a normal: A. Type I and IV hypersensitivity response B. Type II and IV hypersensitivity response C. Type I and III hypersensitivity response D. Type II and III hypersensitivity response

    A. Type I and IV hypersensitivity response

  • 35

    Which of the following symptoms in a young child may indicate an immunodeficiency syndrome? A. Anaphylactic reactions B. Severe rashes and myalgia C. Recurrent bacterial, fungal, and viral infections D. Weight loss, rapid heartbeat, breathlessness

    C. Recurrent bacterial, fungal, and viral infections

  • 36

    What screening test should be performed first in a young patient suspected of having an immune dysfunction disorder? A. Complete blood count (CBC) and white cell differential B. Chemotaxis assay C. Complement levels D. Bone marrow biopsy

    A. Complete blood count (CBC) and white cell differential

  • 37

    Which test should be performed when a patient has a reaction to transfused plasma products? A. Immunoglobulin levels B. T-cell count C. Hemoglobin levels D. Red cell enzymes

    A. Immunoglobulin levels

  • 38

    What is the “M” component in monoclonal gammopathies? A. IgM produced in excess B. μ Heavy chain produced in excess C. Malignant proliferation of B cells D. Monoclonal antibody or cell line

    D. Monoclonal antibody or cell line

  • 39

    A child suspected of having an inherited humoral immunodeficiency disease is given diphtheria/ tetanus vaccine. Two weeks after the immunization, his level of antibody to the specific antigens is measured. Which result is expected for this patient if he/she indeed has a humoral deficiency? A. Increased levels of specific antibody B. No change in the level of specific antibody C. An increase in IgG-specific antibody but not IgMspecific antibody D. Increased levels of nonspecific antibody

    B. No change in the level of specific antibody

  • 40

    In testing for DiGeorge’s syndrome, what type of laboratory analysis would be most helpful in determining the number of mature T cells? A. Complete blood count B. Nitroblue tetrazolium (NBT) test C. T-cell enzyme assays D. Flow cytometry

    D. Flow cytometry

  • 41

    Interpret the following description of an immunofixation electrophoresis assay of urine. Dense wide bands in both the κ and λ lanes. No bands present in the heavy-chain lanes. A. Normal B. Light chain disease C. Increased polyclonal Fab fragments D. Multiple myeloma

    C. Increased polyclonal Fab fragments

  • 42

    Free monoclonal light chains are often present in the serum of multiple myeloma patients, and may be useful for disease monitoring. Which of the following assays would be recommended to detect the presence of serum-free light chains? A. Serum protein electrophoresis B. Urine immunofixation C. Nephelometry D. ELISA

    C. Nephelometry

  • 43

    What is measured in the CH50 assay? A. RBC quantity needed to agglutinate 50% of antibody B. Complement needed to lyse 50% of RBCs C. Complement needed to lyse 50% of antibody sensitized RBCs D. Antibody and complement needed to sensitize 50% of RBCs

    C. Complement needed to lyse 50% of antibody sensitized RBCs

  • 44

    What type of disorders would show a decrease in C3, C4, and CH50? A. Autoimmune disorders such as SLE and RA B. Immunodeficiency disorders such as common variable immunodeficiency C. Tumors D. Bacterial, viral, fungal, or parasitic infections

    A. Autoimmune disorders such as SLE and RA

  • 45

    All of the following tests measure phagocyte function except: A. Leukocyte adhesion molecule analysis B. Di Hydro rhodamine reduction assay C. NBT test D. IL-2 (interleukin-2) assay

    D. IL-2 (interleukin-2) assay

  • 46

    What is the correct procedure upon receipt of a test request for human chorionic gonadotropin (hCG) on the serum from a 60-year-old man? A. Return the request; hCG is not performed on men B. Perform a qualitative hCG test to see if hCG is present C. Perform the test; hCG may be increased in testicular tumors D. Perform the test but use different standards and controls

    C. Perform the test; hCG may be increased in testicular tumors

  • 47

    Which method is the most sensitive for quantitation of AFP? A. Double immunodiffusion B. Electrophoresis C. Enzyme immunoassay D. Particle agglutination

    C. Enzyme immunoassay

  • 48

    How is HLA typing used in the investigation of genetic diseases? A. For prediction of the severity of the disease B. For genetic linkage studies C. For direct diagnosis of disease D. Is not useful in this situation

    B. For genetic linkage studies

  • 49

    Select the best donor for a man, blood type AB, in need of a kidney transplant. A. His brother, type AB, HLA matched for class II antigens B. His mother, type B, HLA matched for class I antigens C. His cousin, type O, HLA matched for major class II antigens D. Cadaver donor, type O, HLA matched for some class I and II antigens

    A. His brother, type AB, HLA matched for class II antigens

  • 50

    Interpret the following microcytotoxicity results: A. Positive for A1 and Aw19; negative for A9 and B12 B. Negative for A1 and Aw19; positive for A9 and B12 C. Error in test system; retest D. Impossible to determine

    B. Negative for A1 and Aw19; positive for A9 and B12

  • 51

    Which method, classically used for HLA-D typing, is often used to determine the compatibility between a living organ donor and recipient? A. Flow cytometry B. Mixed lymphocyte culture (MLC) C. Primed lymphocyte test (PLT) D. Restriction fragment length polymorphism (RFLP)

    B. Mixed lymphocyte culture (MLC)

  • 52

    SITUATION: Cells type negative for all HLA antigens in a complement-dependent cytotoxicity assay. What is the most likely cause? A. Too much supravital dye was added B. Rabbit complement is inactivated C. All leukocytes are dead D. Antisera is too concentrated

    B. Rabbit complement is inactivated

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Which of the following methods used for HIV identification is considered a signal amplification technique? A. Branched chain DNA analysis B. DNA PCR C. Reverse transcriptase PCR D. Nucleic acid sequence-based assay (NASBA)

    A. Branched chain DNA analysis

  • 2

    Which of the following fungal organisms is best diagnosed by an ANTIGEN detection test as opposed to an antibody detection assay? A. Histoplasma B. Cryptococcus C. Candida D. Aspergillus

    B. Cryptococcus

  • 3

    Your cytology laboratory refers a Papanicolaou smear specimen to you for an assay designed to detect the presence of a virus associated with cervical cancer. You perform: A. An ELISA assay for anti-HSV-2 antibodies B. A molecular assay for HSV-2 C. An ELISA assay for HPV antibodies D. A molecular assay for HPV

    D. A molecular assay for HPV

  • 4

    An immunosuppressed patient has an unexplained anemia. The physician suspects a parvovirus B19 infection. A parvovirus IgM test is negative. The next course of action is to tell the physician: A. The patient does not have parvovirus B. A convalescent specimen is recommended in 4 weeks to determine if a fourfold rise in titer has occurred C. A parvovirus PCR is recommended D. That a recent transfusion for the patient’s anemia may have resulted in a false-negative assay and the patient should be retested in 4 weeks

    C. A parvovirus PCR is recommended

  • 5

    What is a general definition for autoimmunity? A. Increase of tolerance to self-antigens B. Loss of tolerance to self-antigens C. Increase in clonal deletion of mutant cells D. Manifestation of immunosuppression

    B. Loss of tolerance to self-antigens

  • 6

    An antinuclear antibody test is performed on a specimen from a 55-year-old woman who has unexplained joint pain. The IFA result is a titer of 40 and a homogeneous pattern. The appropriate followup for this patient is: A. Anti-DNA assay B. Extractable nuclear antigen (ENA) testing C. Retest ANA in 3–6 months D. CH50 complement assay

    C. Retest ANA in 3–6 months

  • 7

    Which disease is likely to show a rim (peripheral) pattern in an immunofluorescence (IF) microscopy test for ANA? A. Mixed connective tissue disease (MCTD) B. Rheumatoid arthritis C. Systemic lupus erythematosus D. Scleroderma

    C. Systemic lupus erythematosus

  • 8

    A patient’s specimen is strongly positive in an ANA ELISA. Which of the following would not be an appropriate follow up to this result? A. Immunofluorescence test on HEp-2 cells B. Specific ENA ELISA tests C. Specific anti-DNA ELISA D. Rheumatoid factor assay

    D. Rheumatoid factor assay

  • 9

    What type of antibodies is represented by the solid or homogeneous pattern in the immunofluorescence test for antinuclear antibodies? A. Antihistone antibodies B. Anticentromere antibodies C. Anti-ENA (anti-Sm and anti-RNP) antibodies D. Anti-RNA antibodies

    A. Antihistone antibodies

  • 10

    What disease is indicated by a high titer of antiSm (anti-Smith) antibody? A. Mixed connective tissue disease (MCTD) B. RA C. SLE D. Scleroderma

    C. SLE

  • 11

    Which disease is least likely when a nucleolar pattern occurs in an immunofluorescence test for antinuclear antibodies? A. MCTD B. Sjögren’s syndrome C. SLE D. Scleroderma

    A. MCTD-

  • 12

    What antibodies are represented by the nucleolar pattern in the immunofluorescence test for antinuclear antibodies? A. Antihistone antibodies B. Anti-dsDNA antibodies C. Anti-ENA (anti-Sm and anti-RNP) antibodies D. Anti-RNA antibodies

    D. Anti-RNA antibodies

  • 13

    Which test would best distinguish between SLE and MCTD? A. Multiplex or ELISA test for anti-SM and anti-RNP B. Immunofluorescence testing using Crithidia as substrate C. Slide agglutination testing D. Laboratory tests cannot distinguish between these disorders

    A. Multiplex or ELISA test for anti-SM and anti-RNP

  • 14

    An ANA test on HEp-2 cells shows nucleolar staining in interphase cells and dense chromatin staining in mitotic cells. The most likely cause of this staining pattern is: A. Antifibrillarin antibody B. Antiribosomal p antibody C. A serum with nucleolar and homogeneous patterns D. Technical artifact

    A. Antifibrillarin antibody

  • 15

    Which immunofluorescence pattern indicates the need for ENA testing by Ouchterlony immunodiffusion, Multiplex, or ELISA assays? A. Homogeneous or solid B. Peripheral or rim C. Speckled D. Nucleolar

    C. Speckled

  • 16

    Which of the following is used in rapid slide tests for detection of rheumatoid factors? A. Whole IgM molecules B. Fc portion of the IgG molecule C. Fab portion of the IgG molecule D. Fc portion of the IgM molecule

    B. Fc portion of the IgG molecule

  • 17

    Which of the following methods is least likely to give a definitive result for the diagnosis of RA? A. Nephelometric measurement of anti-IgG B. Agglutination testing for rheumatoid factor C. Anti CCP D. Immunofluorescence testing for antinuclear antibodies

    D. Immunofluorescence testing for antinuclear antibodies

  • 18

    Which disease might be indicated by antibodies to smooth muscle? A. Atrophic gastritis B. Autoimmune hepatitis C. Myasthenia gravis D. Sjögren’s syndrome

    B. Autoimmune hepatitis

  • 19

    Antibodies to thyroid peroxidase can be detected by using agglutination assays. Which of the following diseases may show positive results with this type of assay? A. Graves’ disease and Hashimoto’s thyroiditis B. Myasthenia gravis C. Granulomatous thyroid disease D. Addison’s disease

    A. Graves’ disease and Hashimoto’s thyroiditis

  • 20

    What is the main use of laboratory tests to detect antibodies to islet cells and insulin in cases of insulindependent diabetes mellitus (IDDM)? A. To regulate levels of injected insulin B. To diagnose IDDM C. To rule out the presence of other autoimmune diseases D. To screen susceptible individuals prior to destruction of β cells

    D. To screen susceptible individuals prior to destruction of β cells

  • 21

    A patient presents with clinical symptoms of celiac disease. Tests for anti-tissue transglutaminase and antigliadin antibodies are negative. Which of the following tests should be ordered? A. IgG level B. HLA DQ typing C. HLA DR typing D. IgM level

    B. HLA DQ typing

  • 22

    A specimen appears to have a perinuclear staining pattern in an antineutrophil cytoplasmic antibody (ANCA) immunofluorescent assay using ethanol fixed neutrophils, suggesting the possibility of a pANCA. On which of the following substrates would this specimen display cytoplasmic speckling? A. Formalin-fixed neutrophils B. Unfixed neutrophils C. HEp-2 cells D. Rabbit kidney tissue

    A. Formalin-fixed neutrophils

  • 23

    Which of the following is a description of a type I hypersensitivity reaction? A. Ragweed antigen cross links with IgE on the surface of mast cells, causing release of preformed mediators and resulting in symptoms of an allergic reaction B. Anti-Fya from a pregnant woman crosses the placenta and attaches to the Fya antigen-positive red cells of the fetus, destroying the red cells C. Immune complex deposition occurs on the glomerular basement membrane of the kidney, leading to renal failure D. Exposure to poison ivy causes sensitized T cells to release lymphokines that cause a localized inflammatory reaction

    A. Ragweed antigen cross links with IgE on the surface of mast cells, causing release of preformed mediators and resulting in symptoms of an allergic reaction

  • 24

    Which in vitro test measures IgE levels against a specific allergen? A. Histamine release assay B. Radioimmunosorbent test (RIST) C. Fluorescent allergosorbent test (FAST) D. Precipitin radioimmunosorbent test (PRIST)

    C. Fluorescent allergosorbent test (FAST)

  • 25

    A patient who is blood group O is accidentally transfused with group A blood and develops a reaction during the transfusion. What antibody is involved in this type II reaction? A. IgM B. IgE C. IgG and IgE D. IgG

    A. IgM

  • 26

    Why is skin testing the most widely used method to test for a type I hypersensitivity reaction? A. It causes less trauma and is more cost effective than other methods B. It has greater sensitivity than in vitro measurements

    B. It has greater sensitivity than in vitro measurements

  • 27

    Which test would measure the coating of red cells by antibody as occurs in hemolytic transfusion reactions? A. Indirect antiglobulin test (IAT) B. Direct antiglobulin test (DAT) C. ELISA D. Hemagglutination

    B. Direct antiglobulin test (DAT)

  • 28

    Which test detects antibodies that have attached to tissues, resulting in a type-II cytotoxic reaction? A. Migration inhibition factor assay (MIF) B. Direct immunofluorescence (IF) C. Immunofixation electrophoresis (IFE) D. Hemagglutination

    B. Direct immunofluorescence (IF)

  • 29

    Which of the following conditions will most likely result in a false-negative DAT test? A. Insufficient washing of RBCs B. Use of heavy chain–specific polyclonal anti-human Ig C. Use of excessive centrifugal force D. Use of a sample obtained by finger puncture

    A. Insufficient washing of RBCs

  • 30

    Which of the following tests is used to detect circulating immune complexes in the serum of some patients with systemic autoimmune diseases such as rheumatoid arthritis? A. Direct immunofluorescence B. Enzyme immunoassay C. Assay of cryoglobulins D. Indirect antiglobulin test

    C. Assay of cryoglobulins

  • 31

    All of the following tests may be abnormal in a type III immune complex reaction except: A. C1q-binding assay by ELISA B. Raji cell assay C. CH50 level D. Mitogen response

    D. Mitogen response

  • 32

    What immune elements are involved in a positive skin test for tuberculosis? A. IgE antibodies B. T cells and macrophages C. NK cells and IgG antibody D. B cells and IgM antibody

    B. T cells and macrophages

  • 33

    A patient receives a transfusion of packed red cells and fresh frozen plasma and develops an anaphylactic, nonhemolytic reaction. She reports receiving a transfusion 20 years earlier. She had no reaction to the previous transfusion, but she did feel “poorly” a few weeks later. Which of the following transfused substances most likely elicited the reaction? A. IgA B. Group A antigen C. Rho (D) antigen D. An antigen belonging to the Duffy system

    A. IgA

  • 34

    A patient deficient in the C3 complement component would be expected to mount a normal: A. Type I and IV hypersensitivity response B. Type II and IV hypersensitivity response C. Type I and III hypersensitivity response D. Type II and III hypersensitivity response

    A. Type I and IV hypersensitivity response

  • 35

    Which of the following symptoms in a young child may indicate an immunodeficiency syndrome? A. Anaphylactic reactions B. Severe rashes and myalgia C. Recurrent bacterial, fungal, and viral infections D. Weight loss, rapid heartbeat, breathlessness

    C. Recurrent bacterial, fungal, and viral infections

  • 36

    What screening test should be performed first in a young patient suspected of having an immune dysfunction disorder? A. Complete blood count (CBC) and white cell differential B. Chemotaxis assay C. Complement levels D. Bone marrow biopsy

    A. Complete blood count (CBC) and white cell differential

  • 37

    Which test should be performed when a patient has a reaction to transfused plasma products? A. Immunoglobulin levels B. T-cell count C. Hemoglobin levels D. Red cell enzymes

    A. Immunoglobulin levels

  • 38

    What is the “M” component in monoclonal gammopathies? A. IgM produced in excess B. μ Heavy chain produced in excess C. Malignant proliferation of B cells D. Monoclonal antibody or cell line

    D. Monoclonal antibody or cell line

  • 39

    A child suspected of having an inherited humoral immunodeficiency disease is given diphtheria/ tetanus vaccine. Two weeks after the immunization, his level of antibody to the specific antigens is measured. Which result is expected for this patient if he/she indeed has a humoral deficiency? A. Increased levels of specific antibody B. No change in the level of specific antibody C. An increase in IgG-specific antibody but not IgMspecific antibody D. Increased levels of nonspecific antibody

    B. No change in the level of specific antibody

  • 40

    In testing for DiGeorge’s syndrome, what type of laboratory analysis would be most helpful in determining the number of mature T cells? A. Complete blood count B. Nitroblue tetrazolium (NBT) test C. T-cell enzyme assays D. Flow cytometry

    D. Flow cytometry

  • 41

    Interpret the following description of an immunofixation electrophoresis assay of urine. Dense wide bands in both the κ and λ lanes. No bands present in the heavy-chain lanes. A. Normal B. Light chain disease C. Increased polyclonal Fab fragments D. Multiple myeloma

    C. Increased polyclonal Fab fragments

  • 42

    Free monoclonal light chains are often present in the serum of multiple myeloma patients, and may be useful for disease monitoring. Which of the following assays would be recommended to detect the presence of serum-free light chains? A. Serum protein electrophoresis B. Urine immunofixation C. Nephelometry D. ELISA

    C. Nephelometry

  • 43

    What is measured in the CH50 assay? A. RBC quantity needed to agglutinate 50% of antibody B. Complement needed to lyse 50% of RBCs C. Complement needed to lyse 50% of antibody sensitized RBCs D. Antibody and complement needed to sensitize 50% of RBCs

    C. Complement needed to lyse 50% of antibody sensitized RBCs

  • 44

    What type of disorders would show a decrease in C3, C4, and CH50? A. Autoimmune disorders such as SLE and RA B. Immunodeficiency disorders such as common variable immunodeficiency C. Tumors D. Bacterial, viral, fungal, or parasitic infections

    A. Autoimmune disorders such as SLE and RA

  • 45

    All of the following tests measure phagocyte function except: A. Leukocyte adhesion molecule analysis B. Di Hydro rhodamine reduction assay C. NBT test D. IL-2 (interleukin-2) assay

    D. IL-2 (interleukin-2) assay

  • 46

    What is the correct procedure upon receipt of a test request for human chorionic gonadotropin (hCG) on the serum from a 60-year-old man? A. Return the request; hCG is not performed on men B. Perform a qualitative hCG test to see if hCG is present C. Perform the test; hCG may be increased in testicular tumors D. Perform the test but use different standards and controls

    C. Perform the test; hCG may be increased in testicular tumors

  • 47

    Which method is the most sensitive for quantitation of AFP? A. Double immunodiffusion B. Electrophoresis C. Enzyme immunoassay D. Particle agglutination

    C. Enzyme immunoassay

  • 48

    How is HLA typing used in the investigation of genetic diseases? A. For prediction of the severity of the disease B. For genetic linkage studies C. For direct diagnosis of disease D. Is not useful in this situation

    B. For genetic linkage studies

  • 49

    Select the best donor for a man, blood type AB, in need of a kidney transplant. A. His brother, type AB, HLA matched for class II antigens B. His mother, type B, HLA matched for class I antigens C. His cousin, type O, HLA matched for major class II antigens D. Cadaver donor, type O, HLA matched for some class I and II antigens

    A. His brother, type AB, HLA matched for class II antigens

  • 50

    Interpret the following microcytotoxicity results: A. Positive for A1 and Aw19; negative for A9 and B12 B. Negative for A1 and Aw19; positive for A9 and B12 C. Error in test system; retest D. Impossible to determine

    B. Negative for A1 and Aw19; positive for A9 and B12

  • 51

    Which method, classically used for HLA-D typing, is often used to determine the compatibility between a living organ donor and recipient? A. Flow cytometry B. Mixed lymphocyte culture (MLC) C. Primed lymphocyte test (PLT) D. Restriction fragment length polymorphism (RFLP)

    B. Mixed lymphocyte culture (MLC)

  • 52

    SITUATION: Cells type negative for all HLA antigens in a complement-dependent cytotoxicity assay. What is the most likely cause? A. Too much supravital dye was added B. Rabbit complement is inactivated C. All leukocytes are dead D. Antisera is too concentrated

    B. Rabbit complement is inactivated